Home » Newsletters » BioWorld Science

BioWorld Science

June 23, 2017

View Archived Issues

Moleculin Biotech reports discovery of follow-on to WP-1122

Takeda initiates phase II study of TAK-935 in developmental or epileptic encephalopathies

FDA's ODAC to evaluate Zepsyre's potential for pediatric cancers

ISU Abxis is enrolling patients in phase I trial of ISU-304

UCB details development of PI3Kdelta inhibitor seletalisib

Patient recruitment begins in phase I trial of LXI-15029 in patients with advanced solid tumors

Phase I data presented for M-3814 in patients with solid tumors

Reata Pharmaceuticals granted FDA orphan drug designation for omaveloxolone

Angion Biomedica enters license agreement with ElexoPharm

Zogenix 's ZX-008 wins FDA orphan drug designation

PharmNovo prepares delta opioid receptor agonist PN-6047 for clinical investigation

Kamada withdraws MAA for inhaled AAT therapy

Zealand Pharma and Beta Bionics report phase IIa data on dasiglucagon with artificial pancreas

U.K.'s MHRA gives positive opinion to idebenone through EAMS for DMD

Pirotinib tested in phase I study in advanced solid tumor patients

Amgen develops PET probe for cytotoxic lymphocyte detection for cancer immunotherapy

DelMar Pharmaceuticals cleared to conduct phase III study of VAL-083 in GBM

Ewopharma acquires rights to several Eisai products

Merck & Co. divulges coagulation factor XIa/kallikrein B inhibitors

AstraZeneca/Cancer Research Technology patent GLS inhibitors

FDA approves subcutaneous Haegarda to prevent HAE attacks

GlaxoSmithKline presents novel UDP-3-O-acyl-GlcNAc deacetylase inhibitors

Sarepta Therapeutics and Genethon sign gene therapy research collaboration for DMD

FDA issues complete response letter for Trintellix

FDA grants orphan drug designation to IMO-2125 for melanoma

SM-04690 shows promise in phase II trial for knee osteoarthritis

FDA approves Tafinlar + Mekinist for BRAF V600E-positive NSCLC

CPI-444 demonstrates clinical activity in patients with NSCLC and RCC

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...